Board Meeting Details
The Board of Directors meeting was held on May 29, 2026, commencing at 03:15 PM and concluding at 04:00 PM, where the audited financial results for the quarter and year ended March 31, 2026 were approved.
Financial Highlights
- Total Income for FY26: ₹494.87 crore, representing a 15.77% growth compared to the previous year's ₹427.47 crore.
- Net Profit (PAT) for FY26: ₹6.68 crore.
- Performance Context: The company stated that second-half performance was impacted by global events, specifically the imposition of tariffs by the USA and subsequently the USA-Iran war.
Segment-Wise Performance (Year Ended March 31, 2026)
- Sale of Paper: Revenue of ₹285.14 crore; Segment Result of ₹55.79 crore.
- Sale of Chemicals: Revenue of ₹138.27 crore; Segment Result of ₹154.42 crore.
- Trading Activity: Revenue of ₹0.11 crore; Segment Result of ₹0.10 crore.
- Net Segment Revenue: ₹424.47 crore.
Balance Sheet Position (as of March 31, 2026)
- Total Equity and Liabilities: ₹46,055.46 lakh
- Shareholders' Funds: ₹25,972.22 lakh (Capital: ₹1,560.00 lakh; Reserves and Surplus: ₹24,412.22 lakh)
- Non-Current Liabilities: ₹8,028.16 lakh
- Current Liabilities: ₹12,055.08 lakh
- Total Assets: ₹46,055.46 lakh
- Non-Current Assets: ₹31,321.79 lakh
- Current Assets: ₹14,733.67 lakh
Cash Flow Statement (FY26)
- Net Cash from Operating Activities (A): ₹2,942.19 lakh
- Net Cash used in Investing Activities (B): (₹945.47) lakh
- Net Cash used in Financing Activities (C): (₹1,152.92) lakh
- Net Increase in Cash (A+B+C): ₹843.80 lakh
- Cash and Cash Equivalents at Year-End: ₹856.46 lakh (up from ₹12.66 lakh at the start of the year)
Basis of Preparation
The financial statement is prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) prescribed under Section 133 of the Companies Act, 2013. Figures for previous periods have been regrouped/recasted where necessary.